Johannes Fruehauf
InvestorGeneral Partner at Mission Biocapital
Cambridge, Massachusetts
Writes $500K checks · typically $1.5M
FoundedQuralis
About
Johannes Fruehauf is a physician‑scientist with clinical experience in Europe and Africa, giving him a global healthcare perspective, and a serial biotech founder who built the LabCentral/BioLabs network supporting early-stage biotech.
Invests in
AgTechBiotechFoodTechHealthtechMedical DevicesNew Materials
Experience
- LabCentralFounder and Chairmancurrent2025 — presentKendall Square, Cambridge
- LabCentralFounder and President/CEO2012 — 2025
- Mission BioCapitalGeneral Partner, Co-Foundercurrent2011 — presentGreater Boston Area
- BioLabsPresident & CEO, Foundercurrent2009 — present
- Zag BioInvestor and Board Membercurrent2023 — present
- Volnay TherapeuticsFounder, President, Member of the Boardcurrent2022 — presentBoston and Europe
- QurAlisBoard Membercurrent2018 — presentCambridge, MA
- Vaxess TechnologiesBoard Member2016 — 2025
- Arkuda TherapeuticsInvestor and Board Member2019 — 2025Watertown, Massachusetts, United States
- Tidal TherapeuticsFounding Investor and Board Director2018 — 2021Cambridge, MA
- TotientFounding Investor and Observer2018 — 2021Cambridge, Massachusetts, United States
- Sentien Biotechnologies, Inc.Board Director2016 — 2021Cambridge, MA
- Pandion TherapeuticsInvestor and Board Observer2018 — 2020Cambridge MA
- Mitokinin IncBoard Director2017 — 2018NYC/SF
- ViThera PharmaceuticalsFounder, Chairman2011 — 2015Cambridge, MA
- Aura BiosciencesVice President, Research and Development2009 — 2011
- Cequent Pharmaceuticals (now Marina Biotech NASDAQ: MRNA)Vice President, Medical Affairs (Consultant)2009 — 2010
- Cequent Pharmaceuticals (now Marina Biotech NASDAQ: MRNA)Vice President, Research2006 — 2010Cambridge, MA
- Cequent Pharmaceuticals (now Marina Biotech NASDAQ: MRNA)Director, Preclinical and Clinical Development2006 — 2007
- BIDMC/Harvard Medical SchoolSenior Research Fellow2004 — 2007
Education
- Harvard Medical SchoolPostdoc, Molecular Biology2002 — 2004
- SLP Boston 2012Fellow, Entrepreneurship/Entrepreneurial Studies2011 — 2012
- Goethe University FrankfurtMD, Medicine1989 — 1997
- University of MontpellierMedicine1994 — 1995
- Franziskaner Gymnasium Kreuzburg
Skills & more
Drug Discovery62Biotechnology95Lifesciences46Clinical Development18Cancer8Clinical Trials13Technology Transfer42In Vivo10Assay Development14Drug Delivery6Start-ups37Entrepreneurship21
+12 more
Molecular BiologyVenture CapitalHealthcareDrug DevelopmentBiochemistryCommercializationPharmaceuticsBiopharmaceuticalsPharmaceutical IndustryINDStrategyCell BiologyLanguages English · French · German
From Johannes's professional profile.
Same school
Also attended Harvard Medical School118
Niko BonatsosInvestment Team at General CatalystAnthony PhilippakisInvestor at GV (Google Ventures)Ben RobbinsInvestor at GV (Google Ventures)David ReshefInvestor at GV (Google Ventures)Krishna YeshwantInvestor at GV (Google Ventures)Morgan CheathamPartner and Head of Healthcare and Life Sciences at Breyer Capital
+ 112 more
Also attended Goethe University Frankfurt39
Marcel HollerbachInvestor at Cavalry VenturesDaniel von DevivereVenture Scout at Storm VenturesLeonard LangAssociate at BlockwallOliver ManojlovicVP Sales at Personio at PICUS CAPITALBill MacCartneyFormer VP ML at Cohere at SignalFireSaid HaschemiInvestor at HV Capital
+ 33 more
Shared employers
Also worked at BioLabs2
Also worked at QurAlis7
Caroline PinkneyInvestor at E12 Venture Capital, LlcSudhir AgrawalInvestor at 82VSMegInvestor at Sanofi VenturesJeffrey MoorePresident at MC Healthcare VenturesArno de WildeInvestor at EQT Life SciencesCillian KingManaging Director at EQT Life Sciences
+ 1 more
Also worked at Vaxess Technologies3
Also worked at Aura Biosciences2
Deals · 1
Vaxess Technologies, Inc.Board seat
via Mission Biocapital · filed Mar 2021 · $2M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Mission Biocapital
Cassidy Blundell
Partner at Mission Biocapital
Chaya Patel
Principal at Mission Biocapital
Chris Carlin
Chief Operations Officer and Chief Compliance Officer at Mission Biocapital
Clay Rowland
Investment Associate at Mission Biocapital
Douglas Crawford
Managing General Partner at Mission Biocapital
Helen Siaw
Analyst at Mission Biocapital
Jennifer Griffin
Partner at Mission Biocapital
Josephine Brysting
Investment Analyst at Mission Biocapital
Network3
Cassidy Blundell
Partner at Mission Biocapital
Chaya Patel
Principal at Mission Biocapital
Douglas Crawford
Managing General Partner at Mission Biocapital
Investors connected to Johannes in public investor directories — a warm-intro map.

.png)









:format(webp))























